JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
Microsoft
MSFT
|
+$6.27B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.61B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.32B |
| 4 |
Meta Platforms (Facebook)
META
|
+$3.21B |
| 5 |
Apple
AAPL
|
+$2.9B |
Top Sells
| 1 |
iShares Short Treasury Bond ETF
SHV
|
+$3.23B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.76B |
| 3 |
Schwab US TIPS ETF
SCHP
|
+$702M |
| 4 |
Nike
NKE
|
+$702M |
| 5 |
Tesla
TSLA
|
+$652M |
Sector Composition
| 1 | Technology | 20.52% |
| 2 | Healthcare | 11.04% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.87% |
| 5 | Industrials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Aramark
ARMK
$10.2B
| $107M | 0.01% |
3,430,717
-994,647
| -22% | -$30.9M |
|
752
Plains All American Pipeline
PAA
$12.2B
| $106M | 0.01% |
7,537,891
-609,247
| -7% | -$8.59M |
|
753
Outset Medical
OM
$251M
| $106M | 0.01% |
323,983
-5,285
| -2% | -$1.73M |
|
754
Revolution Medicines
RVMD
$8.64B
| $106M | 0.01% |
3,967,753
+705,115
| +22% | +$18.9M |
|
755
Saia
SAIA
$8.41B
| $106M | 0.01% |
309,348
-105,453
| -25% | -$36.1M |
|
756
Pinterest
PINS
$23.8B
| $105M | 0.01% |
3,850,814
+2,871,167
| +293% | +$78.5M |
|
757
Twist Bioscience
TWST
$1.55B
| $105M | 0.01% |
5,136,126
+1,078,814
| +27% | +$22.1M |
|
758
First Advantage
FA
$2.83B
| $105M | 0.01% |
6,816,436
+375,624
| +6% | +$5.79M |
|
759
Progyny
PGNY
$1.99B
| $105M | 0.01% |
2,668,574
+95,863
| +4% | +$3.77M |
|
760
TD Synnex
SNX
$12.6B
| $105M | 0.01% |
1,116,277
+126,071
| +13% | +$11.9M |
|
761
Murphy USA
MUSA
$7.59B
| $105M | 0.01% |
336,842
+2,191
| +0.7% | +$682K |
|
762
Western Midstream Partners
WES
$14.6B
| $105M | 0.01% |
3,949,320
-373,649
| -9% | -$9.91M |
|
763
Deutsche Bank
DB
$71.4B
| $104M | 0.01% |
9,891,146
+2,784,472
| +39% | +$29.3M |
|
764
Albertsons Companies
ACI
$10.5B
| $104M | 0.01% |
4,762,924
+459,824
| +11% | +$10M |
|
765
PPL Corp
PPL
$26.6B
| $104M | 0.01% |
3,915,417
-106,011
| -3% | -$2.81M |
|
766
Warner Bros
WBD
$40B
| $103M | 0.01% |
8,240,603
+1,154,924
| +16% | +$14.5M |
|
767
Halliburton
HAL
$19B
| $103M | 0.01% |
3,118,214
+1,118,571
| +56% | +$36.9M |
|
768
Arrowhead Research
ARWR
$4.11B
| $103M | 0.01% |
2,880,914
-29,051
| -1% | -$1.04M |
|
769
KKR & Co
KKR
$129B
| $102M | 0.01% |
1,826,534
+279,057
| +18% | +$15.6M |
|
770
e.l.f. Beauty
ELF
$7.83B
| $102M | 0.01% |
892,327
-90,480
| -9% | -$10.3M |
|
771
Envista
NVST
$3.59B
| $102M | 0.01% |
3,009,433
+217,487
| +8% | +$7.36M |
|
|
BPMC
772
DELISTED
Blueprint Medicines
BPMC
| $102M | 0.01% |
1,608,569
+56,813
| +4% | +$3.59M |
|
773
Southern Copper
SCCO
$85.3B
| $101M | 0.01% |
1,485,293
+416,483
| +39% | +$28.5M |
|
|
AMED
774
DELISTED
Amedisys
AMED
| $100M | 0.01% |
1,096,319
-900,711
| -45% | -$82.4M |
|
775
Outfront Media
OUT
$3.13B
| $100M | 0.01% |
6,478,298
+460,820
| +8% | +$7.13M |
|